| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_18b672c1940bb09c1b5769ee3f57f32a |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2502-1114
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2502-1121
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2502-1107
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2502-094
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2502-1192
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2503-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2502-091
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2502-30 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0651
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0697
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5082 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-00 |
| filingDate |
2008-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_208a5e0564d304d1f84d2c7a5634bb88
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6e1f3622deff1f5b6d0211b487068e8b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_40957af98473e9dc930e2ededfa4ad56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_29be0d39ff3e22f35025ce01ee77470b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cb530dce2f1bba6699c2ddf98bc9c696
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1066882dbe3a755e8dee1cb787e043ab
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2322231d896253063b42babd680143fb |
| publicationDate |
2010-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-2260097-A1 |
| titleOfInvention |
Disease model incorporation into an artificial immune system (ais) |
| abstract |
The present invention relates to methods of constructing an integrated artificial immune system that comprises appropriate in vitro cellular and tissue constructs or their equivalents to mimic the tissues of the immune system in mammals. The artificial immune system can be used to test the efficacy of vaccine candidates and other materials in vitro and thus, is useful to accelerate vaccine development and testing drug and chemical interactions with the immune system, coupled with disease models to provide a more complete representation of an immune response. |
| priorityDate |
2008-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |